C07K 14/375
From basidiomycetes
Official title: from Basidiomycetes
C07K14/375 (From basidiomycetes) appears on 69 US grants and 89 published applications in this corpus.
Search patents in C07K- Granted patents
- 69
- Published applications
- 89
- Assignees
- 80
- Inventors
- 280
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 2 | 6 |
| 2006 | 1 | 4 |
| 2007 | 3 | 6 |
| 2008 | 2 | 1 |
| 2009 | 3 | 1 |
| 2010 | 5 | 6 |
| 2011 | 1 | 3 |
| 2012 | 1 | 4 |
| 2013 | 2 | 4 |
| 2014 | 1 | 5 |
| 2015 | 2 | 8 |
| 2016 | 5 | 8 |
| 2017 | 4 | 3 |
| 2018 | 5 | 1 |
| 2019 | 1 | 4 |
| 2020 | 1 | 3 |
| 2021 | 2 | 0 |
| 2022 | 1 | 2 |
| 2023 | 0 | 7 |
| 2024 | 4 | 5 |
| 2025 | 1 | 1 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Plant pathogen effector and disease resistance gene identification, compositions, and methods of use3 Mar 2026US 12,565,662 B2Huazhong Agricultural University
- Monoacylated MEL-producing microorganism27 Jan 2026US 12,534,749 B2National Institute of Advanced Industrial Science and Technology
- Plant pathogen effector and disease resistance gene identification, compositions, and methods of use11 Nov 2025US 12,467,061 B2Pioneer Hi-Bred International, Inc.
- Immunomodulatory protein for alleviation and/or treatment of coronavirus diseases22 Oct 2024US 12,122,809 B2Mycomagic Biotechnology Co., Ltd.
- Mutants of recombinant immunoregulatory protein of Ganoderma lucidum and applications thereof3 Sep 2024US 12,077,566 B2
- Plants producing proteins for pest control1 Oct 2026US 2026/0297610 A1Kmetijski Institut Slovenije
- Proteins with minimal n-terminal initiator methionine9 Jul 2026US 2026/0193662 A1Unichem Laboratories Ltd
- Methods and compositions of quaternary immunomodulatory nanoparticles for medical applications and immunotherapy25 Jun 2026US 2026/0174841 A1
- Methods for the improved production of psilocybin and intermediates or side products through enzyme optimization11 Jun 2026US 2026/0159865 A1Miami University
- Exosome composition containing ganoderma immunomodulatory protein and uses thereof6 Feb 2025US 2025/0041369 A1Mycomagic Biotechnology Co., Ltd.
Most cited
By later US patents
- Hybrid enzymes17US 7,129,069 B2Novo Zymes Als · 2006
- Glycoprotein isolated from ganoderma having immunosuppressive activity15US 5,334,704 AMeiji Milk Products Co., Ltd. · 1994
- F-18 peptides for pre targeted positron emission tomography imaging15US 7,842,279 B2Immunomedics, Inc. · 2010
- Anticancer drugs13US 4,461,760 ANoda Shokukin Kogyo Co., Ltd. · 1984
- Method for identifying and using biosynthetic genes for enhanced production of secondary metabolites12US 5,108,918 AGist-Brocades N. V. · 1992